CIDD 0067106
CAS No. 2151865-39-1
CIDD 0067106( CIDD0067106 )
Catalog No. M13435 CAS No. 2151865-39-1
CIDD 0067106 is a novel natural product-based diaryloxazole that potent and selective antiproliferative activities against androgen receptor-positive breast cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCIDD 0067106
-
NoteResearch use only, not for human use.
-
Brief DescriptionCIDD 0067106 is a novel natural product-based diaryloxazole that potent and selective antiproliferative activities against androgen receptor-positive breast cancer cells.
-
DescriptionCIDD 0067106 is a novel natural product-based diaryloxazole that potent and selective antiproliferative activities against androgen receptor-positive breast cancer cells (MDA-MB-453 cell GI50=0.8 uM); displays approximately 37.5- to 62.5-fold antiproliferative selectivity for MDA-MB-453 cells over others TNBC cells (MDA-MB-231 GI50=50 uM); inhibits the activity of the mTORC1 pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsCIDD0067106
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptormTOR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2151865-39-1
-
Formula Weight483.99
-
Molecular FormulaC26H30ClN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC)[C@H]1N(CC2=CC=C(C3=NC=C(C4=CC=C(OC/C=C(C)/C)C=C4)O3)N=C2)CCC1
-
Chemical Name(S)-Methyl-1-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)-oxazol-2-yl)pyridin-3-yl)methyl]pyrrolidine-2-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Robles AJ, et al. J Med Chem. 2017 Nov 3. doi: 10.1021/acs.jmedchem.7b01228.
molnova catalog
related products
-
Tretazicar
CB1954(Tretazicar), an anticancer prodrug, is activated by NAD(P)H quinone oxidoreductase 2.
-
mTOR inhibitor 10
A novel potent, selective mTOR inhibitor with biochemical IC50 of 21.7 nM for mTORC1.
-
AZD-8055
A potent, selective, ATP-competitive and orally bioavailable mTOR inhibitor with IC50 of 0.8 nM.
Cart
sales@molnova.com